An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Magellan Health Announces Two New Appointments to Magellan Health Studio Advisory Council
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Magellan Health, Inc. (NASDAQ: MGLN) has appointed two new healthcare experts, Dr. Andrey Ostrovsky and Dr. Harold Pincus, to its Health Studio Advisory Council. These appointments aim to enhance the company's integrated health solutions as they redefine health and wellbeing for customers. Dr. Ostrovsky, former chief medical officer of the U.S. Medicaid program, brings extensive experience in healthcare innovation and policy-making. Dr. Pincus, a professor at Columbia University and director at RAND Corporation, has published over 500 scientific research pieces in health services. The Health Studio was launched in 2020.
Positive
Appointment of two reputable healthcare experts to the Advisory Council.
Dr. Ostrovsky has extensive experience in healthcare innovation and policy.
Dr. Pincus has a strong academic background with numerous publications.
Negative
None.
PHOENIX--(BUSINESS WIRE)--
Magellan Health, Inc. (NASDAQ: MGLN) today announced two new healthcare experts have been appointed to serve on the Magellan Health Studio Advisory Council. The Council consists of leaders who bring their unique perspectives to Magellan as it reinvents the health and wellbeing experience for customers and members through the design and development of integrated, whole person solutions.
The newly appointed members are Dr. Andrey Ostrovsky, managing partner, Social Innovation Ventures, and Dr. Harold Pincus, professor and vice chair of the Department of Psychiatry and co-director of the Irving Institute for Clinical and Translational Research, Columbia University.
“Dr. Ostrovsky and Dr. Pincus are both well-qualified and highly regarded experts, and we look forward to their contributions to the Magellan Health Studio Advisory Council,” said Alisa Bahl, Ph.D., chief strategy and innovation officer, Magellan Healthcare.
Brief biographies of the new Council members follow:
Dr. Ostrovsky was the former chief medical officer of the U.S. Medicaid program and is currently the managing partner at Social Innovation Ventures, where he invests in and advises companies and non-profits dedicated to eliminating disparities. He also advises federal and state regulators on how to incorporate human centered design into policy making. He previously operated a series of methadone clinics in Baltimore, Maryland. Prior to working on the front line of the opioid use disorder crisis, he served as the chief medical officer for the Center for Medicaid and CHIP Services. Dr. Ostrovsky holds a medical doctorate and undergraduate degrees in Chemistry and Psychology magna cum laude from Boston University and is a member of Phi Beta Kappa. He completed his pediatrics residency training in the Boston Combined Residency Program at Boston Medical Center and Boston Children’s Hospital where he was a clinical instructor at Harvard Medical School. He is currently teaching faculty and attending physician at Children’s National Medical Center.
Dr. Pincus is professor and vice chair of the Department of Psychiatry and co-director of the Irving Institute for Clinical and Translational Research at Columbia University. Dr. Pincus also serves as a senior scientist at the RAND Corporation. He is also the national director of the Health and Aging Policy Fellowship (supported by The John A. Hartford Foundation, West Health Institute and Atlantic Philanthropies) and previously directed national programs for the Robert Wood Johnson and MacArthur Foundations. Dr. Pincus has been appointed to the editorial boards of 12 scientific journals and published over 500 scientific publications in health services research, science policy, research career development, quality of care and the diagnosis, classification, and treatment of mental disorders. Dr. Pincus is the 2017 recipient of the C. Charles Burlingame Award by the Institute of Living for contributions to the field of psychiatry and has received the Menninger Award from the American College of Physicians, Research Mentorship Award from the American Association of Chairs of Departments of Psychiatry and APA, Vestermark Award from NIMH and APA, among other honors.
The Magellan Health Studio was launched in 2020 to accelerate the design, development and delivery of integrated solutions for employers, health plans, healthcare systems, providers and ultimately members. Magellan Health Studio conducts human-centered research, explores creative solutions, and engages with key partners to develop and test solutions to improve engagement, health outcomes, and performance.
About Magellan Health: Magellan Health, Inc., is a leader in managing the fastest growing, most complex areas of health, including special populations, complete pharmacy benefits and other specialty areas of healthcare. Magellan supports innovative ways of accessing better health through technology, while remaining focused on the critical personal relationships that are necessary to achieve a healthy, vibrant life. Magellan's customers include health plans and other managed care organizations, employers, labor unions, various military and governmental agencies and third-party administrators. For more information, visit MagellanHealth.com.
